These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 29056146)

  • 1. Corrigendum to 'Evaluation of the cytotoxicity, genotoxicity and mucus permeation capacity of several surface modified poly(anhydride) nanoparticles designed for oral drug delivery' [International Journal of Pharmaceutics 517 (2017) 67-79].
    Iglesias T; de Cerain AL; Irache JM; Martín-Arbella N; Wilcox M; Pearson J; Azqueta A
    Int J Pharm; 2017 Nov; 533(1):320. PubMed ID: 29056146
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of the cytotoxicity, genotoxicity and mucus permeation capacity of several surface modified poly(anhydride) nanoparticles designed for oral drug delivery.
    Iglesias T; López de Cerain A; Irache JM; Martín-Arbella N; Wilcox M; Pearson J; Azqueta A
    Int J Pharm; 2017 Jan; 517(1-2):67-79. PubMed ID: 27908629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro evaluation of the genotoxicity of poly(anhydride) nanoparticles designed for oral drug delivery.
    Iglesias T; Dusinska M; El Yamani N; Irache JM; Azqueta A; López de Cerain A
    Int J Pharm; 2017 May; 523(1):418-426. PubMed ID: 28286081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucus-penetrating nanoparticles: Promising drug delivery systems for the photodynamic therapy of intestinal cancer.
    Anderski J; Mahlert L; Mulac D; Langer K
    Eur J Pharm Biopharm; 2018 Aug; 129():1-9. PubMed ID: 29778525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclodextrin-grafted poly(anhydride) nanoparticles for oral glibenclamide administration. In vivo evaluation using C. elegans.
    Lucio D; Martínez-Ohárriz MC; Gu Z; He Y; Aranaz P; Vizmanos JL; Irache JM
    Int J Pharm; 2018 Aug; 547(1-2):97-105. PubMed ID: 29842888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclodextrin/poly(anhydride) nanoparticles as drug carriers for the oral delivery of atovaquone.
    Calvo J; Lavandera JL; Agüeros M; Irache JM
    Biomed Microdevices; 2011 Dec; 13(6):1015-25. PubMed ID: 21773725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and in vitro evaluation of slippery nanoparticles for enhanced diffusion through native mucus.
    Laffleur F; Hintzen F; Shahnaz G; Rahmat D; Leithner K; Bernkop-Schnürch A
    Nanomedicine (Lond); 2014 Mar; 9(3):387-96. PubMed ID: 23611618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient mucus permeation and tight junction opening by dissociable "mucus-inert" agent coated trimethyl chitosan nanoparticles for oral insulin delivery.
    Liu M; Zhang J; Zhu X; Shan W; Li L; Zhong J; Zhang Z; Huang Y
    J Control Release; 2016 Jan; 222():67-77. PubMed ID: 26686663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overcoming the diffusion barrier of mucus and absorption barrier of epithelium by self-assembled nanoparticles for oral delivery of insulin.
    Shan W; Zhu X; Liu M; Li L; Zhong J; Sun W; Zhang Z; Huang Y
    ACS Nano; 2015 Mar; 9(3):2345-56. PubMed ID: 25658958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo study of the mucus-permeating properties of PEG-coated nanoparticles following oral administration.
    Inchaurraga L; Martín-Arbella N; Zabaleta V; Quincoces G; Peñuelas I; Irache JM
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):280-9. PubMed ID: 25541441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin loaded mucus permeating nanoparticles: Addressing the surface characteristics as feature to improve mucus permeation.
    Pereira de Sousa I; Moser T; Steiner C; Fichtl B; Bernkop-Schnürch A
    Int J Pharm; 2016 Mar; 500(1-2):236-44. PubMed ID: 26802494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucus permeating thiomer nanoparticles.
    Köllner S; Dünnhaupt S; Waldner C; Hauptstein S; Pereira de Sousa I; Bernkop-Schnürch A
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):265-72. PubMed ID: 25603199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corrigendum to: EXPLOITING THE VERSATILITY OF CHOLESTEROL IN NANOPARTICLES FORMULATION (International Journal of Pharmaceutics. 511 (1) (2016) 331-340).
    Belletti D; Grabrucker AM; Pederzoli F; Menrath I; Cappello V; Vandelli MA; Forni F; Tosi G; Ruozi B
    Int J Pharm; 2017 Nov; 533(1):321. PubMed ID: 29056147
    [No Abstract]   [Full Text] [Related]  

  • 14. Development and in vivo evaluation of papain-functionalized nanoparticles.
    Müller C; Perera G; König V; Bernkop-Schnürch A
    Eur J Pharm Biopharm; 2014 May; 87(1):125-31. PubMed ID: 24373995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoparticles decorated with proteolytic enzymes, a promising strategy to overcome the mucus barrier.
    Pereira de Sousa I; Cattoz B; Wilcox MD; Griffiths PC; Dalgliesh R; Rogers S; Bernkop-Schnürch A
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):257-64. PubMed ID: 25661320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Goblet cell-targeting nanoparticles for oral insulin delivery and the influence of mucus on insulin transport.
    Jin Y; Song Y; Zhu X; Zhou D; Chen C; Zhang Z; Huang Y
    Biomaterials; 2012 Feb; 33(5):1573-82. PubMed ID: 22093292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steric and interactive barrier properties of intestinal mucus elucidated by particle diffusion and peptide permeation.
    Boegh M; García-Díaz M; Müllertz A; Nielsen HM
    Eur J Pharm Biopharm; 2015 Sep; 95(Pt A):136-43. PubMed ID: 25622791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled Release, Intestinal Transport, and Oral Bioavailablity of Paclitaxel Can be Considerably Increased Using Suitably Tailored Pegylated Poly(Anhydride) Nanoparticles.
    Calleja P; Espuelas S; Vauthier C; Ponchel G; Irache JM
    J Pharm Sci; 2015 Sep; 104(9):2877-86. PubMed ID: 25600579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and antitumor efficacy of paclitaxel-cyclodextrin complexes loaded in mucus-penetrating nanoparticles for oral administration.
    Calleja P; Espuelas S; Corrales L; Pio R; Irache JM
    Nanomedicine (Lond); 2014 Jul; 9(14):2109-21. PubMed ID: 24471503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved transport and absorption through gastrointestinal tract by PEGylated solid lipid nanoparticles.
    Yuan H; Chen CY; Chai GH; Du YZ; Hu FQ
    Mol Pharm; 2013 May; 10(5):1865-73. PubMed ID: 23495754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.